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Abstract
Viruses rely completely on the hosts’ machinery for translation of viral transcripts. However, for most viruses infecting humans, codon
usage preferences (CUPrefs) do not match those of the host. Human papillomaviruses (HPVs) are a showcase to tackle this paradox:
they present a large genotypic diversity and a broad range of phenotypic presentations, from asymptomatic infections to productive
lesions and cancer. By applying phylogenetic inference and dimensionality reduction methods, we demonstrate first that genes
in HPVs are poorly adapted to the average human CUPrefs, the only exception being capsid genes in viruses causing productive
lesions. Phylogenetic relationships between HPVs explained only a small proportion of CUPrefs variation. Instead, the most important
explanatory factor for viral CUPrefs was infection phenotype, as orthologous genes in viruses with similar clinical presentation
displayed similar CUPrefs. Moreover, viral genes with similar spatiotemporal expression patterns also showed similar CUPrefs. Our
results suggest that CUPrefs in HPVs reflect either variations in the mutation bias or differential selection pressures depending on the
clinical presentation and expression timing. We propose that poor viral CUPrefs may be central to a trade-off between strong viral
gene expression and the potential for eliciting protective immune response.
Key words: human viruses, codon usage preferences, mutation, translational selection, immune system, clinical presentation,
genotype–phenotype, warts, cancer, chronic infection, acute infection.
Introduction
Synonymous codons are not used at random (Aota and
Ikemura 1986; Shields and Sharp 1987). Codon usage prefer-
ences (CUPrefs) vary between species, and between genes
within the same genome (Marin et al. 1989). CUPrefs have
arisen from a complex interplay between several evolutionary
processes, essentially mutation and selection (Bulmer 1991).
The mutational model postulates that the main factor
influencing average codon usage is nucleotide composition
(Guanine-Cytosine [GC] content) in the genome (Chen et al.
2004). This model considers changes in synonymous codon
usage neutral: It assumes that no fitness effect is associated
with the preferential use of a given synonymous codon
(Plotkin and Kudla 2011). The selection-related model postu-
lates coadaptation between synonymous codon usage and
the translation machinery (e.g., differential transfer RNA
[tRNA] abundance) to optimize translational speed and en-
hance translational accuracy (Sharp et al. 1995; Duret 2000;
Rocha 2004). Hence, the selection model claims that synony-
mous mutations can indeed influence the fitness of an organ-
ism (Plotkin and Kudla 2011). The mutation model and the
selection model are not mutually exclusive. In fast-growing
organisms with large population sizes, such as Escherichia
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coli or Saccharomyces cerevisiae, experimental evidence sup-
ports the idea that translation selection is the main factor
conditioning CUPrefs (Stenico et al. 1994; Moriyama and
Powell 1997). In contrast, in slowly growing organisms with
small population sizes, such as mammals, natural selection
may be inefficient to strongly pattern CUPrefs, and its effect
on codon usage remains controversial (Duret 2002). Besides
selection for translational efficiency and accuracy, the choice
of synonymous codons may also be under the selective pres-
sure for optimal translation kinetics, to ensure correct messen-
ger RNA (mRNA) structure and protein folding (Plotkin and
Kudla 2011). Inappropriate CUPrefs may impair translation
kinetics, thus leading to fitness costs associated to low quan-
tity of functional protein, but also to waste of cellular re-
sources incurred through accumulation of erroneous and
misfolded protein, increased toxicity, and cleaning costs
(Gingold and Pilpel 2011).
Codon usage in viruses seems to be shaped both by selec-
tion and mutation. On one side, all viruses depend on host
translational machinery, in particular viruses that do not
encode their own tRNAs (as it is the case for human viruses),
and CUPrefs in viral genes tend to match protein-specific re-
quirements (Akashi and Eyre-Walker 1998): proteins required
in large amount are usually encoded by genes optimized to
the host CUPrefs, while maladaptation of CUPrefs results in
reduced protein production (Bahir et al. 2009). On the other
side, genomic GC content is often a strong predictive variable
for codon usage in viruses (Sharp and Li 1986; Karlin et al.
1990), revealing that genome-wide mutational pressures play
an important role in patterning viral CUPrefs (Shackelton et al.
2006). Other studies suggest that additional selective factors
such as fine-tuning selection on translation kinetics and
escape from antiviral cellular responses may also underlie
viral CUPrefs (Sugiyama et al. 2005; Aragones et al. 2008,
2010).
Papillomaviruses (PVs) are nonenveloped, double-stranded
DNA viruses with a circular genome of approximately 8 kbp.
PVs infect epithelia in a wide spectrum of vertebrates, at cu-
taneous and mucosal sites (Bravo and Felez-Sanchez 2015).
The PV life cycle depends on keratinocyte differentiation
(Bedell et al. 1991). Viral genomes are primarily present as
nuclear episomes, which replicate in parallel to cell division.
As the daughter cell migrates upwards and undergoes differ-
entiation, the viral DNA is amplified and the viral expression
pattern is modified, eventually leading to nonlytic virion re-
lease (Longworth and Laimins 2004). PV genomes typically
contain eight well-defined open reading frames (ORFs) classi-
fied as early (E1, E2, E4, E5, E6, and E7) and late (L1 and L2)
based on their temporal expression during viral life cycle. The
early E5, E6, and E7 oncoproteins induce cell immortalization
and transformation; E1 and E2 are associated with viral
genome replication; and the E4 protein is associated with
cytokeratin filament collapse. The late L1 and L2 genes
encode for capsid proteins that are strongly immunogenic
(Zheng and Baker 2006).
Human PVs belong to five monophyletic genera
(supplementary fig. S1, Supplementary Material online):
Alphapapillomaviruses (AlphaPVs), Betapapillomaviruses
(BetaPVs), Gammapapillomaviruses (GammaPVs),
Mupapillomaviruses (MuPVs), and Nupapillomaviruses
(NuPVs) (Bernard et al. 2010). In PV taxonomy, two PV ge-
nomes sharing more than 60% nucleotide identity in the L1
gene belong to the same PV genera (de Villiers et al. 2004).
Different human PV lineages have adapted to specific epithe-
lial niches, with different types showing differences in cell
tropism, natural history of the infection, prevalence, and as-
sociation with disease (Bravo and Felez-Sanchez 2015). The
large majority of the hitherto known human PVs, essentially
Beta- and GammaPVs, cause asymptomatic infections and
can be detected in healthy skin swabs or, for a reduced
number of GammaPVs, also in mucosal rinses (Nindl et al.
2007). Mu- and NuPVs cause conspicuous, productive cuta-
neous lesions usually at palmar and plantar epithelial sites
(Bernard et al. 2010). Finally, AlphaPVs are very diverse in
terms of tropism and clinical manifestation of the disease.
They include viruses with cutaneous tropism causing warts
in the hands, lips, or eyelids; viruses with a very defined tro-
pism and causing sexually transmitted warts and condylomas;
and viruses causing less productive, long-lasting infections as-
sociated with certain human cancers, such as cervical cancer,
other anogenital cancers, and a fraction of head and neck
tumors (Bernard et al. 2010). Thus, there is no sharp corre-
spondence between clinical manifestation and phylogenetic
relationships for human PVs, as members from different
genera could produce similar clinical presentations (e.g.,
Beta- and GammaPVs essentially causing asymptomatic mu-
cocutaneous lesions [MucCutAsym]), but certain viruses be-
longing to the same genera could cause different clinical
presentations (e.g., AlphaPVs can cause cutaneous warts
[CutW], genital warts [GenW], or other mucosal lesions
[MucL]).
PVs do not encode for any element of the transcription or
the translation machinery. They rely on the host cellular appa-
ratus for gene expression and it would be expected that PV
CUPrefs match those of the host. It is thus puzzling, however,
that CUPrefs in human PVs are different from CUPrefs in
humans (Zhao et al. 2003; Bravo and Müller 2005): the pre-
ferred codons in human PV genes are the less-preferred
codons in the average human genes (Bravo and Müller
2005) and show a strong bias toward codons ending with
Adenine/Thymine [A/T] (Bravo and Müller 2005; Cladel et al.
2010). These compositional differences possibly reflect a bias
in the mutation/selection evolutionary processes that still
needs to be understood. Hitherto, two adaptive explanations
for the biased CUPrefs in PV genes have been proposed. First,
it has been suggested that PV CUPrefs have been selected for
because they decrease viral protein synthesis, thereby
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lowering immune exposure (Tindle 2002; Cid-Arregui et al.
2003). Second, it has been postulated that PV CUPrefs may
have evolved to differentially match the varying tRNA profile
of the host cell in which viral protein actually occurs: the dif-
ferentiating keratinocyte (Zhou et al. 1999; Gu et al. 2004;
Aragones et al. 2010; Cladel et al. 2010).
We have analyzed here the CUPrefs for 156 human PVs
from five distinct phylogenetic groups to determine whether
variations in CUPrefs could be explained by differences in
tissue tropism, association with disease, and/or timing of
gene expression. Due to the high dimensionality of CUPrefs
data, dimensionality reduction techniques were applied:
Multidimensional scaling (MDS), correspondence analysis
(CA), and cluster analyses.
Materials and Methods
Human PVs Gene Sequences
The ORFs of all human PVs available at the Papillomavirus
Episteme Database (http://pave.niaid.nih.gov ) were collected
between March and April 2013. Using an in-house PERL script,
the ORFs were examined by checking the start codon, stop
codon, and internal stop codons to guarantee that only true
ORFs were used. The final data set included 156 HPV types: 63
AlphaPVs, 45 BetaPVs, 45 GammaPVs, 2 MuPVs, and 1 NuPV.
Names, accession numbers, and other information are de-
tailed in supplementary table S1, Supplementary Material
online.
Clinical Manifestations of Human PV Infections
Human PVs were classified according to their phenotypic cli-
nical presentation characteristics. This classification took into
account both the nature of the infection and its tropism. As
for the nature of the infection, most human PVs are recovered
from healthy skin and healthy mucosa, and generate unap-
parent, nonproductive infections. Other PVs cause highly pro-
ductive infections that cause self-limited benign proliferative
lesions, chiefly warts. Finally, a few human PVs cause long-
lasting, low productive infections that can lead to the
development of malignant proliferative lesions, essentially
anogenital cancers (Doorbar et al. 2012). As for tropism,
human PV infections are either mucosal or cutaneous. The
following four groups were defined (supplementary fig. S1,
Supplementary Material online, and supplementary table S1,
Supplementary Material online): Mucocutaneous asymptom-
atic (MucCutAsym), including Beta and GammaPVs that cause
unapparent infections; GenW group, including AlphaPVs
causing proliferative lesions at mucosal sites; MucL group con-
tained AlphaPVs causing other lesions at mucosal sites and
with potential for malignisation; finally, the CutW group in-
cluded Alpha-, Mu-, and NuPVs causing proliferative cutane-
ous lesions.
Codon Usage Preferences Data
Detailed codon composition for each genus is provided in
supplementary table S4, Supplementary Material online.
Patterns of synonymous codon usage were analyzed in the
E1, E2, E4, E6, E7, L1, and L2 genes. The E5 gene was ex-
cluded from the analysis because it is absent in most human
PVs. The relative frequency (RF) distribution of 59 codons (ex-
cluding Met, Trp, and stop codons) was calculated using an in-
house PERL script. The abundance of each codon in a gene
was calculated and pondered by a factor corresponding to the






where nac is the number of events in which the c-th codon for
the a-th amino acid is used, and ta the total number of syno-
nymous codons that encode the ath amino acid. The final
representation of the codon usage data for each gene is
thus a vector of 59 positions with values between 0 and 1.
We calculated the pairwise CUPrefs distances as the
Euclidean distances between the RF vectors of the corre-
sponding human PVs.
Codon Adaptation Index
To analyze the relationship of CUPrefs between human PVs
and humans, we employed the codon adaptation index
(CAI) (Sharp and Li 1987). This index evaluates the match
between the CUPrefs of a particular gene and those in a
reference set. In our case, the reference values were the
average CUPrefs in the human genome, as retrieved from
the Kazusa codon usage database, under http://www.
kazusa.or.jp/codon/cgi-bin/showcodon.cgi?species=9606,
last accessed April 2013) (Nakamura et al. 2000). CAI
values were calculated for all human PV genes. CAI
values were also calculated for the subset of human
genes differentially expressed in the epithelium. Epithelial
genes were retrieved from the UCSC browser in May 2015
(Kent et al. 2002) filtering skin genes by their expression
(log2(tissue/reference) with a maximum value of 5 and
minimum of5). No differences in CUPrefs were identified
in genes underexpressed or overexpressed in skin com-
pared with the average CUPrefs. We therefore chose the
CAI values for the subset of epithelial genes as a reference
(supplementary fig. S2, Supplementary Material online).
CAI was calculated using in-house PERL Scripts. For each
gene, the output of the CAI calculation was a single value,
between 0 and 1, with higher values reflecting a higher
similarity in CUPrefs to the reference. The maximum value
of 1 is only achieved if, for each synonymous codons set, all
amino acids in the considered gene are encoded by the
most used codon in the reference set.
Viral Codon Usage and Infection Phenotype GBE
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Dimensionality Reduction Methods: Multidimensional
Scaling and Correspondence Analysis
Our final data set for analysis was a matrix in which the
rows correspond to the genes of one human PV genome
and the columns to the 59 codons, such that each row has
the codon usage information for a specific gene, in terms
of relative frequencies. This data set was subjected to di-
mensionality reduction techniques to analyze similarities
among codon usage of human PV genes, by applying
MDS and CA.
MDS refers to a broad class of procedures that create low-
dimensional representations of complex data with preserva-
tion of the similarities between data points (Cox TF and Cox
MAA 1994). In an n-dimensional representation, samples with
very similar codon usage profiles are displayed close together.
We performed a nonmetric MDS with column wise Z-trans-
formation of the variables using SPSS Statistics Version 17.0
(IBM, Chicago IL). For MDS analysis, the matrix based on
codon RF values was used in order to avoid biases linked to
amino acid composition. In order to determine the appropri-
ate dimensionality in which data should be scaled, we used
scree plots (data not shown), which display stress as a function
of dimensionality. Based on the stress values and on interpret-
ability, we chose two dimensions as the “best” solution to
plot our data.
CA consists in a multivariate statistical method widely used
to summarize the lack of independence between objects rep-
resented through rows and columns of a matrix (here genes
and codons, respectively) as a small number of derived vari-
ables, called axes. By definition, the axes are ordered accor-
ding to the amount of variance in the data explained by them.
Data were plotted on the first two axes with the information
on the amount of variance explained in these two-dimensional
representations.
CA of codon usage data is a widely used method in
sequence analysis, which can be refined through internal
correspondence analysis (ICA) to account for the variability
in amino acid composition between proteins as a con-
founding factor when one wants to analyze synonymous
codon usage variability. ICA, which is basically a double
within-between-CA, has been found to be the best
method in generating axes that reflect variations in synon-
ymous codon usage (Suzuki et al. 2008). This method fur-
ther allows distinguishing within and between group
variability with respect to genotype, gene, or clinical man-
ifestations. ICA was run in R-3.0.1 with package ade4-
1.5.2 and cross-checked with the implementations in
vegan-2.0.9 and FactoMineR-1.25. We additionally used
seqinr-3.0.7 for computing codon usage counts and
boot1.3-11 for bootstrapping to assess the variance in
each codon’s contribution to the first principal axis under
sampling from a sequence population. Here, we sampled
with replacement from the population of all PVs,
performed the ICA, and obtained the projections of
codons on the first axis of the ICA. Repeating this 1,000
times rendered a distribution of projections that informed
us on how reliable the ICA analysis is with regards to sam-
pling from a population.
Cluster Analysis
Statistical clustering was used to determine the optimal
number of natural conglomerates within the data, and to
classify each individual gene into one of the identified con-
glomerates (Kent and Kongsted 2012). We applied the statis-
tical clustering technique implemented as two-step cluster
analysis (SPSS Statistics; IBM). The first step groups the cases
into many small subclusters. The second step groups the
subclusters into the final, optimal number of clusters, esti-
mated using the Bayesian information criterion (BIC).
Phylogenetic Analysis
Amino acid sequences were aligned with MUSCLE (Edgar
et al. 2004) and back-translated into codon-aligned nucleotide
sequences. Informative positions were filtered with GBLOCKS
under nonstringent conditions (Castresana 2000).
Phylogenetic relationships were inferred in a maximum like-
lihood framework using RAxML v.8 (http://www.exelixis-lab.
org/) (Stamatakis 2014) at the nucleotide level. We used the
GTR+ 4 model, considering three partitions (one per codon
position). The number of required bootstrap cycles was deter-
mined with the –autoMRE command (Stamatakis 2014).
Pairwise evolutionary distances between terminal taxa were
estimated on the best-known maximum likelihood tree using
RAxML.
Statistical Analysis
The Huber’s M-estimator calculated with R was used as robust
central estimator for CAI values. The significance of the differ-
ences in CAI values between PV genes and human genes was
tested with a Wilcoxon and Mann–Whitney (WMW) test, im-
plemented in R package stats. The effect of clinical presenta-
tion and gene (and their interaction) on CAI values was tested
through a two-way analysis of variance (ANOVA) followed by
Tukey post hoc test (SPSS Statistics; IBM). Pearson’s correla-
tions (implemented in R) were used to determine if there was
a relationship between evolutionary and codon usage-based
distances. Moreover, in order to identify major sources of var-
iation among human PVs on the axes generated by ICA, we
tested for the correlation between projections to the first prin-
cipal axis with CAI and average GC content at the third posi-
tion in 4-fold family codons and also for the 4-fold component
in the 6-fold family codons, for each gene separately.
Pearson’s correlation (r) was calculated. The square of r indi-
cated the percentage of the variance in the first axis that is
explained by the variance in the gene feature values.
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Results
Genes in Human PVs Do Not Follow Human Codon
Usage Preferences
We first evaluated the global adaptation of CUPrefs in human
PV genes to the human CUPrefs, by calculating the CAI (Sharp
and Li 1987). This index evaluates the match between the
CUPrefs of a particular gene and those in a reference set, in
our case the human average CUPrefs. CAI values were calcu-
lated for each gene in the human PV data set. Because human
PVs infect epithelial cells, CAI values were also calculated for
the subset of human genes expressed in the epithelium.
Figure 1 shows the cumulative frequency of CAI for human
epithelial genes and for each gene in the human PVs. For all
human PV genes, frequency distributions are shifted to lower
CAI values compared with the reference human epithelial
FIG. 1.—Cumulative frequency plot showing the distribution of CAI values of HPVs and human epithelial genes. CAI values for HPV genes were
calculated for every gene separately, using the human mean codon usage as a reference set. CAI values of HPV genes are represented in black. CAI values for
human genes expressed at epithelial cells are represented in grey. Statistical differences in CAI values between human and HPV genes were assessed by a
WMW test.
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genes. WMW tests showed that for each of the seven human
PV genes, the median CAI value is significantly lower than the
median CAI value for the human epithelial genes (P<0.001).
A Kolmogorov–Smirnov (KS) test demonstrated further that
for all human PV genes the distribution of the CAI values were
significantly different from that of human genes (P<0.001).
All these results point toward a low level of adaptation of the
human PV genes to the CUPrefs of their host.
Capsid Genes in Human PVs Causing Cutaneous Warts
Present a Greater Adaptation to Human Codon Usage
In order to understand the link between CUPrefs and virus
clinical presentation, we analyzed CAI values stratifying
human PVs by their clinical presentation, essentially in terms
of productivity of the lesion and tropism. Four groups were
defined (supplementary fig. S1, Supplementary Material
online, and supplementary table S1, Supplementary Material
online): MucCutAsym PVs including mucocutaneous human
PVs typically associated with unapparent infections belonging
to BetaPVs and GammaPVs; GenW group including AlphaPVs
causing proliferative lesions at mucosal sites; MucL group in-
cluding other AlphaPVs causing other lesions at mucosal sites
and with potential for malignization; and finally, the cutane-
ous warts group (CutW) including Alpha-, Mu-, and NuPVs
causing proliferative cutaneous lesions.
We observed that CAI values to the human average for all
viral genes and for all viral clinical presentations were statisti-
cally lower than CAI values for human epithelial genes (WMW
test, P< 0.001; KS test, P< 0.001). The only exception was
the L1 capsid gene of human PVs causing cutaneous warts
(WMW test, P> 0.5). CAI cumulative distributions for each
gene and clinical presentation are represented in figure 2
and central values are given in supplementary table S2,
Supplementary Material online. All genes in human PVs are
thus poorly adapted to the average human CUPrefs, indepen-
dently of their clinical presentation, to the exception of one of
the capsid genes in the very productive group of viruses caus-
ing cutaneous warts.
A two-way ANOVA with clinical presentation, gene, and
their interaction as factors was performed to analyze its effect
on CAI values (table 1). This analysis revealed that all factors
had a significant effect. The significant “clinical presenta-
tiongene” interaction indicated that different genes from
human PVs with different clinical presentation had different
degrees of adaptation to the average human CUPrefs. Then a
one-way ANOVA followed by Tukey test was performed for
each gene with clinical presentation as factor (supplementary
table S2, Supplementary Material online). For the E1, E6, L1,
and L2 genes, human PVs causing cutaneous warts showed
significantly greater adaptation to human CUPrefs (P< 0.005,
Tukey post hoc test) than those with other clinical presenta-
tions. The lowest level of adaptation in L1 and L2 was found in
the MucCutAsym group (P< 0.005, Tukey post hoc test). In
contrast, for the E1 and E6 genes, the lowest level of adapta-
tion was seen in mucosal PVs (P< 0.005, Tukey post hoc test).
For E2, the highest level of adaptation was found in the
MucCutAsym group, and the lowest in PVs causing MucLs
(P< 0.005, Tukey post hoc test) (fig. 2 and supplementary
table S2, Supplementary Material online). Finally, for E7 and
E4, all cutaneous PVs—MucCutAsym and CutW—showed
higher adaptation to the average human CUPrefs than muco-
sal PVs—GenW and MucL (fig. 2 and supplementary table S2,
Supplementary Material online).
We also performed a one-way ANOVA followed by Tukey
test for each clinical manifestation with gene as a factor (fig.
S2 and supplementary table S2, Supplementary Material
online). For Human PVs causing CutW, GenW, and MucL,
the L1 gene showed the highest level of adaptation to
human CUPrefs (P< 0.005, Tukey post hoc test). In contrast,
for MucCutAsym human PVs, late genes (L1 and L2) showed
the lowest level of adaptation. The highest level of adaptation
in MucCutAsym was found in E4, whereas for GenW and
MucL, the E4 gene exhibited the lowest level of adaptation
(P< 0.005, Tukey post hoc test) (supplementary fig. S3,
Supplementary Material online, and supplementary table S2,
Supplementary Material online).
The E2 Hinge Region Shows Higher Adaptation to
Human CUPrefs than the Overlapping E4 Gene
The E4 ORF is nested within the E2 sequence in a different
reading frame, with the E4 coding sequence overlapping the
so-called hinge region of the E2 gene (fig. 3A). To assess the
influence of the presence of an overlapping region on
CUPrefs, we calculated the CAI values for the E2 hinge
region, containing E4, as well as for the nonoverlapping
region (fig. 3B). We performed a WMW paired test in order
to compare the adaptation of these two regions for each
human PV. We found that the CAI values for the hinge
region were significantly higher than those for the nonover-
lapping region. Moreover, the E2 hinge region also showed
significantly higher degree of adaptation compared with E4
(P< 0.005, WMW paired test). We performed the same anal-
ysis but stratifying each human PV by their clinical manifesta-
tion (supplementary fig. S4, Supplementary Material online).
The results of the WMW paired test indicated again that for all
clinical manifestations the CAI values for the E2 hinge region
were significantly higher than those for the nonoverlapping
region (supplementary fig. S4, Supplementary Material
online). Also, for all clinical manifestations, the CAI values
for E2 hinge region were significantly higher than for E4.
Finally, we found that for MucL and GenW, E4 genes were
significantly less adapted than E2 genes. On the contrary, for
MucCutAsym and CutW, we found the opposite pattern, with
E2 being significantly less adapted than E4 (supplementary fig.
S4, Supplementary Material online).
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Evolutionary Distances Explain only a Low Proportion of
Codon Usage Differences
In order to address the relationship between CUPrefs in
human PVs and their evolutionary history, we analyzed the
correlation between pairwise evolutionary distances and pair-
wise CUPrefs distances for each of the seven genes studied
(fig. 4). Pairwise evolutionary distances were calculated from
the best-known tree reconstructed by maximum likelihood
techniques (see Methods). Pairwise CUPrefs distances were
FIG. 2.—Cumulative frequency plot of CAI values for human and HPV genes stratified by clinical manifestation. CAI values of each HPV gene were
computed on the basis of CUPrefs in human genes. In green are represented CAI values of mucocutaneous asymptomatic HPVs (both Beta- and
GammaPVs). In red, HPVs that cause mucosal lesions. In yellow, HPVs that cause genital warts. In blue, HPVs causing cutaneous warts. In black, human
epithelial genes.
Table 1
Effect of Clinical Manifestation and Gene on CAI
Factor df F ratio P value
Clinical manifestation 3 74.52 <0.001
Gene 6 33.16 <0.001
Clinical manifestationgene 18 16.69 <0.001
NOTE.—A two-way ANOVA was performed to assess the influence of clinical
manifestation (mucocutaneous asymptomatic, mucosal lesions, genital warts, and
cutaneous warts) and gene (E6, E7, E1, E2, E4, L1, and L2) on CAI. Both factors and
their interaction show a significant effect on CAI. df, degree of freedom.
Viral Codon Usage and Infection Phenotype GBE
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calculated as the Euclidean distances between relative fre-
quencies vectors of synonymous codon usage. They represent
the similarities in terms of codon usage between pairs of
PVs. The correlation between both variables was significant
and positive for all genes, with r2 ranging from 0.01 (E4) to
0.41 (E2) with a median value of 0.19. This means that on
average, evolutionary distances explained only a fifth of the
variance in codon-based distance. No clear trend was obvious
depending on gene expression timing, as early genes dis-
played both the highest and the lowest r2, for E2 and E4,
respectively.
Orthologous Genes in Viruses with Similar Clinical
Presentation Display Similar Codon Usage Preferences
In order to elucidate common patterns on CUPrefs among
human PVs, MDS in combination with cluster analysis was
performed for each gene independently. The 59 RF variables
in the CUPrefs matrix were reduced to two dimensions using
MDS procedure (fig. 5). The closer to one another two points
lie in this two-dimensional space, the more similar the two
corresponding taxa are in terms of codon usage. However,
MDS does not classify individuals into clusters, and it is impos-
sible to capture all the variability of the multidimensional data
in a lower dimensional display. Hence, in parallel and indepen-
dently of MDS, we performed a tag-free two-step cluster anal-
ysis on the 59 relative frequencies variable matrix for each
gene independently. The optimal number of clusters was
also inferred blindly using the BIC. The results of the cluster
analysis were incorporated into the MDS plot in figure 5 (see
also clustering analysis results in table 2).
In line with our previous findings (fig. 4), common ancestry
did not explain similarity in CUPrefs, as the cluster analysis did
not identify the three main genera, Alpha-, Beta-, and
GammaPVs (supplementary table S3, Supplementary
Material online), for any gene. Instead, the main factor driving
codon usage-based grouping was virus clinical presentation,
as MucCutAsym including Beta- and GammaPVs appeared
together for all genes, both for cluster and MDS analysis.
Human PVs in the MuPV genus, which cause cutaneous
warts, grouped together with very distant PVs in the
AlphaPV genus and associated with similar clinical manifesta-
tions. Furthermore, HPV41, the only member in the NuPV
genus, which has been associated with cutaneous warts, clus-
tered together with the MucCutAsym group. HPV4 and
HPV65, classified as GammaPVs but associated to cutaneous
warts, also appeared together with CutW group. The analyses
also revealed that for all genes (except for E6, due to
the absence of this gene in certain GammaPVs) three
GammaPVs (in species Gamma-6) grouped with the phyloge-
netically distant GenW group. Finally, we found that HPV32
and HPV54, belonging to the GenW group, appeared to-
gether with CutW group in L1 and L2 for HPV32 and L1 for
HPV54.
Viruses in the AlphaPVs genus (encompassing viruses
with different clinical presentations, namely GenW, CutW,
and MucL) clustered together only for the E7 and E4
genes, but grouped separately for other genes, according to
their clinical presentation (fig. 5). For E6, the main driving
factor for CUPrefs was productivity of the infections, as
CutW and GenW groups clustered together, separate
from MucL. On the other hand, for E1, E2, L2, and L1, the
main driving factor seemed to be tropism, as the GenW
and MucL groups (both with mucosal tropism) clustered
separately from viruses in the CutW group (cutaneous
tropism).
FIG. 3.—(A) Schematic map of the E2 and E4 genes. The E4 ORF
overlaps the hinge region of the E2 gene. This region is a flexible, essen-
tially disordered connector between the functionally conserved transcrip-
tion activation domain and the DNA-binding domain. (B) Cumulative
frequency plot of E2 and E4 genes, and the overlapping and nonoverlap-
ping region of both genes. CAI values of each HPV gene were computed
on the basis of CUPrefs in human genes. Code for genes: Orange, E2;
brown, E4; violet, E2 hinge region; and green, E2 nonoverlapping region
with E4.
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We also performed ICA, a different method of dimension-
ality reduction, in order to cross-validate the MDS results
(fig. 6). ICA is a powerful CA method for the analysis of syn-
onymous codon usage (Suzuki et al. 2008). It is able to disso-
ciate the effects of amino acid composition from the effects
directly related to synonymous codon usage. Both
approaches, ICA and MDS, rendered globally similar results,
further sustaining the claim that clinical presentation was the
main driving factor of CUPrefs in human PVs.
Differences in GC Content in the Third Position and in
Codon Adaptation Index Partly Account for Codon
Usage Preferences
In order to identify major sources of variation among genes on
the axes generated by ICA of codon usage data, we assessed
separately for each gene the linear correlation between pro-
jections on the first principal axis and values of CAI and of
average GC content in the third codon position of 4-fold
degenerate codon families and in the 4-fold component of
FIG. 4.—Scatter plot of the evolutionary distances and the CUPref-based distances in the complete data set for each HPV gene. For all plots, x-axis
represents evolutionary pairwise distances and y-axis represents CUPref-based pairwise distances. Phylogenetic distances were obtained with RAxML for
every gene separately. The correlation coefficient and P value obtained after Pearson’s analysis are reported for each bivariate analysis.
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6-fold degenerate codon families (GC3_4) (fig. 7 and supple-
mentary figs. S5–S11, Supplementary Material online). Both
CAI and average GC content appeared as important sources
of variation in L1 and L2 genes. For E6 and E1 genes, only GC
content correlated significantly with the first ICA axis. For E7,
E2, and E4, none of these gene features correlated with the
first axis of the ICA. These results demonstrate that both gene
features contribute to variations in synonymous codon usage
FIG. 5.—MDS plot of codon usage differences among HPVs. The different HPVs are classified by an unsupervised two-step clustering algorithm, and
visualized by MDS dimension reduction. The clusters are colored yellow (cluster1), blue (cluster 2), and green (cluster 3), respectively. Cluster analysis has been
conducted for each gene separately; for this reason, “cluster 1” represents a totally independent set of PVs for each gene. Each symbol represents one
individual HPV, and the distance between points is proportional to the overall dissimilarity of CUPrefs. Codes for phenotypic presentation of the infection:
Squares, mucocutaneous asymptomatic; dots, mucosal lesions; inverse triangles, genital warts; triangles, cutaneous warts.
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among genes, but their contributions vary among different
genes as also may vary the correlations between GC3_4 con-
tent and CAI.
Differences in Gene Temporal Expression Largely
Determine Differential Codon Usage Preferences
Finally, we approached the connection between CUPrefs of
the different genes and the corresponding gene expression
patterns, analyzing separately the three main genera, that is,
Alpha-, Beta-, and GammaPVs, by means of unsupervised
two-step clustering. For each genus, the optimal number of
clusters was automatically determined using the BIC criterion.
For every genus, gene temporal expression was the main
factor driving data clustering (fig. 8 and table 3), and genes
expressed simultaneously during virus life cycle showed similar
CUPrefs and clustered together. For AlphaPVs, the late genes
largely differed in CUPrefs from the early genes, which
showed a larger variability. Two-step clustering also clustered
late stage genes L1 and L2 together for BetaPVs and
GammaPVs in combination with some early stage genes
(fig. 8). We confirmed the results obtained by MDS using
ICA, which however shows subtle differences in particular
for the E2 gene (fig. 9).
Discussion
We have sought to understand the differential contribution of
the different evolutionary forces shaping human PV CUPrefs.
We first assessed adaptation to the host’s CUPrefs, and
showed that all genes in human PVs display poor adaptation
to human CUPrefs. Our null, most parsimonious, hypothesis
was that CUPrefs in human PVs should be close to CUPrefs in
humans, because: 1) PVs do not encode for any element in-
volved in translation and rely completely on their host’s cell
machinery to translate their genes and 2) the relationship of
these viruses with their amniote hosts lineage is ancient
(Garcia-Vallve et al. 2005; Gottschling et al. 2011; Bravo
and Felez-Sanchez 2015). Deviation from host’s CUPrefs
may lead to inefficient translation, in terms of decreased
amount of translated protein, decreased quality of the synthe-
sized protein, and/or decreased amount of properly folded
protein (Bravo and Müller 2005; Drummond and Wilke 2008).
We tried then to evaluate whether closely related PVs dis-
played closely related CUPrefs. Our analyses revealed however
that evolutionary distances between PVs explain only a small
fraction of CUPref variation among human PVs (fig. 4). Similar
analyses in Herpesviruses had also shown that codon usage
cannot be explicitly tied to species evolution (Roychoudhury
and Mukherjee 2009). Furthermore, we found that Euclidean
Table 2
Distribution of HPVs by their Clinical Presentation in Each Conglomerate Obtained by Two-Step Cluster Analysis
E6a, % E7, %
Cluster1 Cluster2 Cluster3 Cluster1 Cluster2
MucCutAsym (n = 90) 97.8 — 2.2 94.4 5.6
MucL (n = 25) — 100 — — 100
GenW (n = 13) — — 100 — 100
CutW (n = 28) 3.6 — 96.4 3.6 96.4
E1, % E2, % E4, %
Cluster1 Cluster2 Cluster3 Cluster1 Cluster2 Cluster3 Cluster1 Cluster2
MucCutAsym (n = 90) 94.4 3.4 94.4 94.4 3.4 2.2 94.4 5.6
MucL (n = 25) — 100 — — 100 — — 100
GenW (n = 13) — 100 — — 100 — — 100
CutW (n = 28) 3.6 — 3.6 3.6 — 96.4 3.6 96.4
L2, % L1, %
Cluster1 Cluster2 Cluster3 Cluster1 Cluster2 Cluster3
MucCutAsym (n = 90) 94.4 3.4 2.2 94.4 3.4 2.2
MucL (n = 25) — 100 — — 100 —
GenW (n = 13) — 92.3 7.7 — 84.6 15.4
CutW (n = 28) 3.6 — 96.4 3.6 — 96.4
Table should be read as follows, taking E7 as an example: For E7, two-step cluster analysis identifies two different clusters: Cluster 1 spans 94.4% (n =85) of MucCutAsym
HPVs and 3.6% (n= 1) of HPVs causing CutW. Cluster 2 spans 100% (n =25) of HPV causing mucosal lesions, 100% (n= 13) of HPVs causing GenW, 96.4% (n =27) of HPVs
causing CutW and 5.6% (n =5) of HPVs causing MucCutAsym infections.
aCutA in E6, n =87.
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FIG. 6.—ICA plots of synonymous CUPrefs among HPVs. The different HPVs are classified by an unsupervised two-step clustering algorithm. Cluster
analysis has been conducted for each gene separately; for this reason, “cluster 1” represents a totally independent set of PVs in for each gene. Each symbol
represents an individual HPV, and the distance between points is proportional to the overall dissimilarity of CUPrefs. Codes for phenotypic presentation of the
infection: Squares, mucocutaneous asymptomatic; dots, mucosal lesions; inverse triangles, genital warts; triangles, cutaneous warts.
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FIG. 7.—Projections of the first principal axis in combination with either CAI or GC content at the third position of 4-fold degenerated codon families and
at the 4-fold component of the 6-fold degenerated codon families (GC3_4). Codes for phenotypic presentation of the infection: Squares, mucocutaneous
asymptomatic; dots, mucosal lesions; inverse triangles, genital warts; triangles, cutaneous warts.
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distances within AlphaPVs based on CUPrefs were larger than
within BetaPVs or within GammaPVs distances (supplemen-
tary fig. S12, Supplementary Material online). We interpret
that large Euclidean CUPrefs-based distances between
AlphaPVs reflect the broad diversity in clinical presentations
for these viruses, spanning viruses with cutaneous and muco-
sal tropisms. Our results suggest that clinical variables related
to tropism, productivity, and immune exposure could be re-
sponsible for variation in CUPrefs in PVs. Indeed, detailed anal-
yses by means of different methods of dimensionality
reduction (MDS and ICA) showed that orthologous genes in
viruses with similar clinical presentation display similar patterns
of CUPrefs.
A major finding obtained through unsupervised cluster
analysis of viral CUPrefs was an almost perfect match between
groups of viruses showing similar CUPrefs and the clinical,
phenotypic presentation of the infection in terms of tropism,
productivity, and potential for malignization (figs. 5 and 6). A
reduced number of human PVs were initially possible excep-
tions to this pattern, as they presented a tissue tropism diffe-
rent from the rest of their sister taxa. However, a closer
analysis showed that indeed viruses with exceptional tropism
also displayed exceptional CUPrefs compared with their ge-
netically close counterparts: 1) Gamma-6 PVs phylogenetically
group with asymptomatic cutaneous GammaPVs, but were
isolated from cervical lesions (Chen et al. 2007; Nobre et al.
2008), and CUPrefs of Gamma-6 PVs are similar in all six genes
to those of AlphaPVs causing GenW, and not to GammaPVs;
2) two members of Gamma-1 PVs (HPV2 and HPV65) ex-
hibited similar CUPrefs to those of CutWarts, consistent
FIG. 8.—MDS plot of codon usage differences for HPV genes within each genus. HPVs are classified by an unsupervised two-step clustering algorithm
and visualized by MDS dimension reduction. The clusters are colored yellow (cluster1), blue (cluster 2), and green (cluster 3), respectively. Codes for genes:
Squares, E6; diamonds, E7; triangles, E1; inverse triangles, E2; crosses, E4; stars, L2; circles, L1.
Table 3
Distribution of Genes Stratified by Genera in Each Conglomerate of the Two-Step Cluster Analysis
AlphaPVs, % (n = 63) BetaPVs, % (n = 45) GammaPVsa, % (n = 45)
Cluster 1 Cluster 2 Cluster 3 Cluster 1 Cluster 2 Cluster 3 Cluster 1 Cluster 2 Cluster 3
E6 100 — — — 100 — 100 — —
E7 100 — — 100 — — 100 — —
E1 — 100 — — 100 — — 100 —
E2 — 100 — — 100 — — 100 —
E4 100 — — — — 100 — — 100
L2 — — 100 — 100 — — 100 —
L1 — — 100 — 100 — — 100 —
NOTE.—Table should be read as follows taking AlphaPVs as an example: For AlphaPVs, two-step cluster analysis distinguishes three different clusters. Cluster 1 groups E6,
E7, and E4 genes. Cluster 2 groups E1 and E2 genes. Finally, cluster 3 groups L1 and L2 genes.
aFor E6, n =42.
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with their association with skin warts (Chen et al. 1993; Iftner
et al. 2003); and 3) MuPVs, causing cutaneous warts, shared
common CUPrefs in all genes with AlphaPVs also causing cu-
taneous warts, although these viruses show large phyloge-
netic distances. Remarkably, HPV41, the only member of
NuPV genus, showed similar CUPrefs to viruses causing
MucCutAsym infections. Although this virus has been associ-
ated to cutaneous warts, it has also been associated with
squamous cell carcinoma lesions as it has also been the case
for some BetaPVs (Forslund et al. 2007).
We tried finally to evaluate whether gene expression pat-
tern during the virus life cycle could also influence CUPrefs.
We found a strikingly sharp pattern with genes expressed at
similar stages of the viral infection cycle sharing similar
CUPrefs (figs. 7 and 8). In AlphaPVs, genes clustered sepa-
rately into three groups depending on their CUPrefs. Early
genes involved in replication exhibited similar patterns of
codon usage, which differ from codon usage patterns of on-
cogenes (E4, E6, and E7). Finally, structural genes (L1 and L2)
expressed in differentiated keratinocytes also shared patterns
of CUPrefs. It had been described that early genes (E1 and E2)
in AlphaPVs differed in codon usage from late genes (L1 and
L2) (Cladel et al. 2010). Our results thus suggest that in
AlphaPVs, differential CUPrefs match differences in temporal
expression. Such differences may reflect changes in tRNA
availability, as it has been reported that keratinocytes express
different tRNA profiles as they differentiate (Zhao et al. 2005).
In Beta- and GammaPVs, the gene clustering based on
CUPrefs was different from that found in AlphaPVs. Life
cycle in Beta- and GammaPVs has not been studied in detail
and little information is available about the temporal expres-
sion of the genes from these viruses (Doorbar et al. 2012).
Their transcription patterns, life cycle, and other molecular
characteristics are often inferred by homology with those of
the best-described AlphaPVs. This might lead to an overgene-
ralization of the HPV biology, overlooking the fact that diffe-
rent PVs within a given genus are not genetically
homogeneous and that different PVs infecting the same
host (here human PVs within Alpha- and BetaPVs) might
indeed present different biologies (Cladel et al. 2010; Bravo
and Felez-Sanchez 2015). We propose that studying CUPrefs
of PVs infecting the same host could allow inferring life-cycle
characteristics that could then be experimentally explored.
The E4 gene is expressed following a splice event including
a small number of amino acids from the E1 gene, while most
of the coding sequence overlaps the hinge region of the E2
gene in a different reading frame. The E2 hinge region is
a flexible connector between the functionally conserved
transcription activation domain and the DNA-binding
domain (fig. 3A) (Ham et al. 1991; Eriksson et al. 1999). We
have evaluated the influence of the overlapping nature of the
E2 and E4 reading frames on their CUPrefs (fig. 3). Our anal-
yses revealed first that for all clinical manifestations the E4
gene was less adapted to human CUPrefs than the E2 hinge
region; and second that the E2 nonoverlapping region was
also significantly less adapted than the hinge region (fig. 3B).
This is a striking result for two main reasons. On the one hand,
because previous studies on the differential evolution of these
FIG. 9.—ICA showing variance of synonymous CUPrefs between genes of HPV genera. The difference between genes in terms of synonymous codon
usage is shown for Alpha-, Beta-, and GammaPVs (from left to right). Codes for genes: Squares, E6; diamonds, E7; triangles, E1; inverse triangles, E2; crosses,
E4; stars, L2; circles, L1.
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overlapping ORFs had shown that the E4 region presents an
excess of synonymous mutations, compared with and excess
of nonsynonymous mutation in the E2 hinge region (Hughes
AL and Hughes MA 2005; Narechania et al. 2005). Hence,
diversifying selection in the hinge region of E2 coexists with
purifying selection on the overlapping region of E4
(Narechania et al. 2005). In this context, our results suggest
that purifying selection in E4 concurs with deadaptation to
human CUPrefs, thus implying that lowering CAI values to
the human average could indeed be adaptive. On the other
hand because the E2 hinge region is essentially disordered but
displays the highest CAI values to the human average
(Rancurel et al. 2009)This is in sharp contrast with previous
findings showing that disordered proteins tend to be encoded
by genes with poor CUPrefs (Zhou et al. 2015). Overall our
results for the E2/E4 gene pair suggest that we are still far from
understanding the evolutionary interplay between overlap-
ping genes, and that CUPrefs may play a major role that
may not be captured by the standard dN/dS analyses.
The evolutionary forces shaping CUPrefs are basically mu-
tation and/or selection, and they are not always easy to dis-
entangle. Mutational pressures are produced by differential
probability of different nucleotide exchange types, leading
to nucleotide composition biases and eventually shaping
CUPrefs (Shackelton et al. 2006; Belalov and Lukashev
2013). We have shown that nucleotide composition of
human PV genes differs from that of human genes, in line
with previous results (Bravo and Müller 2005; Cladel et al.
2010). Our analysis also revealed a correlation between GC
composition and CUPrefs of different viral clinical presenta-
tions for the E1, E6, L1, and L2 genes (fig. 7). As some authors
assume that GC3_4 composition reflects to some extent mu-
tational pressure, this correlation would suggest that muta-
tional pressures have a role patterning CUPrefs of human PVs
genes, as it has been proposed for other DNA viruses
(Shackelton et al. 2006). However, PVs do not encode for
any element of the genome replication machinery and rely
instead in cellular polymerases for replication (Park et al.
1994). Mutational biases associated to viral DNA replication
should thus a priori be similar to those associated with cellular
DNA replication, but it does not seem to be the case. Several
mutation-based explanations between viral and cellular repli-
cation may account for the observed compositional differ-
ences. First, nucleotide composition biases in the human
genome reflect mutational biases during replication in the
germinal line, while nucleotide composition biases in PVs re-
flect mutational biases during replication in somatic cells
(Martincorena et al. 2015). Analogously, the spectrum of mu-
tations accumulated in human cancers is different from that
arising through common ancestry (Temiz et al. 2015). Second,
PV DNA is the target of the APOBEC3 internal mutators, a
family of cellular cytidine deaminases that introduce direc-
tional C> T substitutions (Vartanian et al. 2008). The
APOBEC3 locus has been under strong selection in the
primate lineage, possibly reflecting an arms race between
virus and host (Munk et al. 2012). In this sense, the decreased
GC content in human PVs, but also in most human DNA vi-
ruses, could reflect the sustained edition pressure by the
APOBEC3 proteins (Vartanian et al. 2010). Additionally,
some experimental studies (Chen et al. 2010; Turabelidze
et al. 2014) have shown differences in APOBEC3 expression
patterns between oral mucosa and cutaneous skin, thus al-
lowing for differential edition of PV genomes depending on
their tropism. Third, viral genome replication in PVs infecting
sun-exposed keratinocytes will be subject to a higher mutation
rate via the error-prone mechanisms of resolution and repair
of cyclobutane pyrimidine dimers (Protic-Sabljic et al. 1986).
Thus, nucleotide bias in human PV genes with respect to
human genes may be accounted for to some extent by differ-
ences in biochemical environment and in gene expression con-
text in infected cells compared with the germinal line.
Regarding adaptation, CUPrefs can increase viral fitness by
directly modulating protein production and by indirectly mod-
ulating immune exposure and expression timing. The counter-
intuitive result of selection on PV CUPrefs is that expression of
PV genes in human cell culture from the wild-type gene se-
quence leads to very low protein amounts, independently of
the promoter and the cell line used. Instead, high gene ex-
pression levels are only achieved when the gene sequence has
been “humanized” by modification of CUPrefs (Liu et al.
2002; Cid-Arregui et al. 2003; Disbrow et al. 2003;
Mossadegh et al. 2004; Samorski et al. 2006; Gruener et al.
2007; Cladel et al. 2008). We communicate here a correlation
between the adaptation to human codon usage and CUPrefs
of different viral clinical presentations in E6, L1, and L2 (fig. 7),
suggesting an important role of adaptation in shaping
CUPrefs of at least these genes in human PVs. Our analyses
reveal that the only exceptions to the systematic CUPrefs mal-
adaptation are the capsid genes (L1 and L2) of human PVs
causing cutaneous warts, which show the highest similarity to
human CUPrefs. We interpret that the observed variation in
mismatch between human PV genes and human CUPrefs is
related to differential virus clinical presentation. Cutaneous
warts are very productive lesions, and the infected keratino-
cytes contain a large amount of virions that are released when
dead cells shed off from skin surface (Doorbar et al. 2012).
Productive lesions require large amounts of the capsid proteins
and we propose that the increased similarity with human
CUPrefs in late genes of PVs causing cutaneous warts en-
hances gene expression by facilitating capsid protein synthesis.
For viruses in other viral families, the highest levels of adapta-
tion of viral proteins to host’s CUPrefs are also observed for
proteins appearing abundantly in the virion (Karlin et al. 1990;
Bahir et al. 2009). Although GenW are also productive lesions,
capsid genes in human PVs responsible for these infections do
not show a higher adaptation to human CUPrefs. We suggest
that differences on their human codon usage adaptation may
arise from differences in productivity between the two wart
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types, as it has been demonstrated that human PVs causing
GenW produce fewer virions compared with those producing
cutaneous warts (Peh et al. 2002). In contrast, Beta- and
GammaPVs also have a mucocutaneous tropism but different
clinical presentation (asymptomatic infections) and showed
lower adaptation to human CUPrefs in the capsid components
of the virion (L1 and L2). CUPref maladaptation could be adap-
tive if decreased protein synthesis lead to a less intense host
immune response (Tindle 2002). Because L1 and L2 are the
most immunogenic proteins (Hibma 2012), we propose that
limiting the expression of structural proteins by means of
codon usage maladaptation allows these viruses to better
escape immune surveillance for a prolonged period of time
without compromising their life cycle. These findings are sup-
ported by previous reports showing that seroprevalence
against Beta- and GammaPVs exhibits a delayed but long-last-
ing antibody response: the immune response was low in chil-
dren and increased continuously with age (Iftner et al. 2010).
In human PVs causing MucCutAsym infections, the highest
level of adaptation to human CUPrefs was found in the E4
gene. In some cutaneous infections, E4 can be expressed at
higher levels than the virion coat proteins, and can account for
as much as 30% of the total protein content (Doorbar 2013).
We hypothesize that an evolutionary trade-off exists in virus
clinical presentation between a potential for strong gene ex-
pression and a potential for eliciting strong immune responses.
Modulation of viral CUPrefs with respect to the host’s CUPrefs
may help push the equilibrium in one direction or another. For
viruses associated to chronic infections, such as human PVs,
the adaptive strategy could thus be to sacrifice virion produc-
tivity to avoid the generation of strong, protective immune
responses, resulting in long-lasting infections and allowing
for reinfection of a previously infected host. For viruses asso-
ciated to acute infections, on the contrary, large virion pro-
duction is accompanied by induction of a strong immune
response that may eventually render the infected host nonsus-
ceptible to subsequent reinfections by closely related viruses.
Experimental evidence of innate immune activity of the schla-
fen 11 gene against viral infections further sustains our hy-
pothesis. Expression of schlafen 11 is triggered by cellular
exposure to interferon, as a response to viral infections
(Sohn et al. 2007). The activity of schlafen 11 protein is to
selectively inhibit translation from mRNAs enriched in A/T-
ending codons (Li et al. 2012), and many viruses infecting
mammals are enriched precisely in A/T-ending codons
(Jenkins and Holmes 2003; Shackelton et al. 2006). The
result is that, as a response against a viral infection, the cellular
machinery shuts down specifically the translation of transcripts
that are potentially of viral origin, using CUPrefs as a guide for
pinpointing viral transcripts.
In summary, we have presented here a thorough analysis of
CUPrefs in human PV genes, connecting codon preferences
with virus infection clinical presentation and with gene expres-
sion patterns. We have shown that, for viruses with a well-
characterized infection cycle, genes expressed simultaneously
tend to show similar CUPrefs. Furthermore, closely related vi-
ruses did not necessarily display closely related CUPrefs, while
orthologous genes in distantly related viruses but with similar
tropism tend to show similar CUPrefs. Finally, we propose that
modulation of viral CUPrefs, as a result of differential mutation
and/or selection pressures, may have an adaptive value, as
they may strongly condition expression efficiency, virion pro-
duction, immune exposure, and propensity toward chronic/
acute virus lifestyle. Comparative research, with insight into
the different life-history traits of virus lifestyle and not remain-
ing merely on descriptions of preferences, will be required to
elucidate the role and the evolutionary forces fuelling the evo-
lution of viral CUPrefs.
Supplementary Material
Supplementary tables S1–S4 and files S1–S12 are available at
Genome Biology and Evolution online (http://www.gbe.
oxfordjournals.org/).
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